{
    "medicine_id": "57fa8dcdb985212197c0c7c5c5b3e7bcc08ab2cf",
    "platform_id": "DB09274",
    "metadata": {
        "name": "Artesunate 60 mg Injection powder for solution",
        "composition": "60 mg Artesunate",
        "clinical_particulars": {
            "therapeutic_indications": "Artesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients L14099",
            "contraindications": {
                "disease": "Data regarding overdoses of artesunate are rare L14099 Patients experiencing an overdose may present with pancytopenia melena seizures multiorgan failure and death L14099 Treat overdose with symptomatic and supportive measures L14099",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Artesunate is an artemisinin derivative that is metabolized to DHA which generates free radicals to inhibit normal function of _Plasmodium_ parasites A18389 L891 L14099 It has a short duration of action due to its short half life and a moderate therapeutic index L891 L14099 Patients should be counselled regarding the risk of post treatment hemolytic anemia and hypersenstivity L14099",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The risk or severity of adverse effects can be increased when Artesunate is combined with Dapsone"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Artesunate can be decreased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Artesunate can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Artesunate can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The metabolism of Artesunate can be decreased when combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Artesunate can be decreased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Artesunate can be decreased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Artesunate can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Artesunate can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Artesunate can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Artesunate can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB13609",
                        "description": "The metabolism of Artesunate can be decreased when combined with Umifenovir"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Artesunate can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Artesunate can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The metabolism of Artesunate can be decreased when combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Artesunate can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The metabolism of Artesunate can be decreased when combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Artesunate can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Artesunate can be decreased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Nevirapine resulting in a loss in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}